Work

A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning

Year: 2020

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Psychological Medicine

DOI: 10.1017/s0033291720003335

Authors: Keith H. Nuechterlein, Joseph Ventura, Kenneth L. Subotnik, Denise Gretchen-Doorly, Luana R. Turner, Laurie R. Casaus, John Luo, Michael L. Boucher, Jacqueline N. Hayata, Morris D. Bell, Alice Medalia

Institutions: University of California, Los Angeles, Yale University, Columbia University Irving Medical Center

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Mental Health

Awards: Developmental Processes in Schizophrenic Disorders, Center for Neurocognition and Emotion in Schizophrenia

OpenAlex ID: W3089236033

FWCI: 3.824

Cites: 48

Cited by: 44

Related to: 10